View in EDS HTML Full Text PDF Full Text

Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.

Saved in:
Bibliographic Details
Title: Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.
Authors: Grivas P; Department of Medicine, Division of Oncology, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, Seattle, WA, 98109, USA. pgrivas@uw.edu., Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ, USA., Petrylak D; Department of Urology, Yale University School of Medicine, New Haven, CT, USA., Reck M; Department of Thoracic Oncology, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Lung Clinic Grosshansdorf, Grosshansdorf, Germany., Foley G; Pfizer Ltd., Tadworth, UK., Guenther S; Merck KGaA, Darmstadt, Germany., Hennessy D; EMD Serono, Rockland, MA, USA., Makris C; Pfizer Inc., New York, NY, USA., Moehler M; Johannes-Gutenberg University, University Medical Center, Mainz, Germany.
Source: Targeted oncology [Target Oncol] 2019 Oct; Vol. 14 (5), pp. 505-525.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31535338
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grivas+P%22">Grivas P</searchLink>; Department of Medicine, Division of Oncology, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, Seattle, WA, 98109, USA. pgrivas@uw.edu.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Petrylak+D%22">Petrylak D</searchLink>; Department of Urology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Department of Thoracic Oncology, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Lung Clinic Grosshansdorf, Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22Foley+G%22">Foley G</searchLink>; Pfizer Ltd., Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Guenther+S%22">Guenther S</searchLink>; Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Hennessy+D%22">Hennessy D</searchLink>; EMD Serono, Rockland, MA, USA.<br /><searchLink fieldCode="AU" term="%22Makris+C%22">Makris C</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Moehler+M%22">Moehler M</searchLink>; Johannes-Gutenberg University, University Medical Center, Mainz, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2019 Oct; Vol. 14 (5), pp. 505-525.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31535338
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11523-019-00665-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 505
    Titles:
      – TitleFull: Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grivas P
      – PersonEntity:
          Name:
            NameFull: Monk BJ
      – PersonEntity:
          Name:
            NameFull: Petrylak D
      – PersonEntity:
          Name:
            NameFull: Reck M
      – PersonEntity:
          Name:
            NameFull: Foley G
      – PersonEntity:
          Name:
            NameFull: Guenther S
      – PersonEntity:
          Name:
            NameFull: Hennessy D
      – PersonEntity:
          Name:
            NameFull: Makris C
      – PersonEntity:
          Name:
            NameFull: Moehler M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2019 Oct
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1776-260X
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Targeted oncology
              Type: main
ResultId 1